arrow
T

Thomas Callahan

Cleveland Clinic Foundation
H指数:28
被引数:3,022

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of prophylactic protamine administration following atrial fibrillation ablation on vascular and pericardial complications

房颤消融术后预防性注射鱼精蛋白对血管和心包并发症的影响

2026-04-130
OA
Intracardiac echocardiography guided anatomical approach to cardioneuroablation: feasibility and outcomes

心脏内超声心动图引导的解剖学方法进行心神经消融术:可行性与结果

2025-12-010
PRE
Pulsed-Field Ablation of Atrial Flutter

心房扑动脉冲场消融术

2025-08-130
OAAI
Catheter Ablation of Atrial Fibrillation in Antiarrhythmic Drug Naïve Patients

房颤导管消融术在抗心律失常药物初治患者中的应用

2025-07-090
PRE
Role of the Bridge balloon in improving the safety of transvenous lead extraction procedures

桥接球囊在经静脉导线移除手术中提高安全性的作用

2025-06-260
OAAI
Pulsed field ablation with a pentaspline catheter for ventricular arrhythmias: First US series

使用五极消融导管进行脉冲场消融治疗室性心律失常:首个美国系列研究

2025-06-130
PRE
Prolonged hospitalization after catheter ablation of ventricular tachycardia: Predictors and outcomes

室性心动过速导管消融术后住院时间延长的预测因素和结局

2025-06-030
OAAI
Procedural outcomes and predictors of lead extraction requiring a bailout femoral approach from a prospective registry at a large volume US center

经静脉导线移除术采用股动脉补救途径的手术结局及预测因素:一项来自美国大型医疗中心的前瞻性注册研究

2025-06-030
PRE
Substrate characterization and outcomes of catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy and isolated apical scar

非缺血性扩张型心肌病合并孤立性心尖部瘢痕患者的心室心动过速导管消融的基质特征及结局

2025-03-260
PRE
Late-gadolinium enhancement predicts appropriate device therapies in nonischemic recipients of primary prevention implantable cardioverter-defibrillators

晚期钆增强可预测非缺血性原发性预防植入式心律转复除颤器受体的适当设备治疗

2025-01-100
OAAI